Showing results (381-390 of 1,292) with videos related to
Sort By:
Pageof 130
Gan No Rinsho. Japan Journal of Cancer Clinics|November 1, 1987
[A clinical evaluation of CA 125 levels in serum, ascites and pleural effusion]K Jibiki, R Demura, Y Abe, et al.European Journal of Pharmacology|November 21, 1989
Renal hemodynamic responses to 5-hydroxytryptamine (5-HT): involvement of the 5-HT receptor subtypes in the canine kidneyT Shoji, T Tamaki, K Fukui, et al.The Journal of Biological Chemistry|March 18, 2000
Subtype-specific trafficking of endothelin receptorsY Abe, K Nakayama, A Yamanaka, et al.Controlled Clinical Trials|December 1, 1996
The Lipoprotein and Coronary Atherosclerosis Study (LCAS): design, methods, and baseline data of a trial of fluvastatin in patients without severe hypercholesterolemiaM S West, J A Herd, C M Ballantyne, et al.JAMA|July 7, 1989
Effects of cyclosporine therapy on plasma lipoprotein levelsC M Ballantyne, E J Podet, W P Patsch, et al.Diabetologia|December 1, 2006
Circulating oxidised low-density lipoprotein and intercellular adhesion molecule-1 and risk of type 2 diabetes mellitus: the Atherosclerosis Risk in Communities StudyR C Hoogeveen, C M Ballantyne, H Bang, et al.American Journal of Physiology. Heart and Circulatory Physiology|April 6, 2000
A chronic mouse model of myocardial ischemia-reperfusion: essential in cytokine studiesT O Nossuli, V Lakshminarayanan, G Baumgarten, et al.Journal of Immunology (Baltimore, Md. : 1950)|August 1, 1993
Gene targeting yields a CD18-mutant mouse for study of inflammationR W Wilson, C M Ballantyne, C W Smith, et al.Clinical Therapeutics|April 11, 2001
Efficacy and tolerability of fluvastatin extended-release delivery system: a pooled analysisC M Ballantyne, F Pazzucconi, X Pintó, et al.Metabolism: Clinical and Experimental|October 10, 1997
Effect of 1 alpha-hydroxyvitamin D3 on serum levels of thyroid hormones in hyperthyroid patients with untreated Graves' diseaseT Kawakami-Tani, E Fukawa, H Tanaka, et al.Pageof 130